Original title:&nbsp;Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis.&nbsp;Reference:&nbsp;David H. Adams et al. N Engl J Med. 2014 Mar 29. [Epub ahead of print]. Transcatheter Aortic valve replacement (TAVR) with balloon expandable valve showed survival improvement in inoperable patients and was similar to surgery inoperable high-risk patients. An alternative to the above device is the self-expandable<a href="https://solaci.org/en/2014/04/09/core-valve-in-high-risk-patients-superior-to-surgical-replacement-at-one-year/" title="Read more" >...</a>

Original title:&nbsp;Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Diabetes and Severe Aortic Stenosis at High Risk for Surgery An Analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve).&nbsp;Reference:&nbsp;Lindman BR et al. J Am Coll Cardiol. 2014 Mar 25;63(11):1090-9. Diabetes is associated to greater morbidity and mortality after surgical aortic valve replacement (SAVR),<a href="https://solaci.org/en/2014/03/26/transcatheter-aortic-valve-replacement-showed-better-results-than-conventional-surgery-in-high-risk-diabetic-patients/" title="Read more" >...</a>

Original title:&nbsp;Relation of Pre-procedural Assessment of Myocardial Contractility Reserve on Outcomes of Aortic Stenosis Patients with Impaired Left Ventricular Function Undergoing Transcatheter Aortic Valve Implantation&nbsp;Reference:&nbsp;Israel M. Barbash et al. Am J Cardiol. 2014, Epub ahead of print. &nbsp; Transcatheter aortic valve replacement (TAVI) is associated with a better left ventricular function (LV) in patients with<a href="https://solaci.org/en/2014/03/19/transcatheter-aortic-valve-replacement-in-patients-with-low-ejection-fraction-comparable-outcomes-with-good-ejection-fraction-patients/" title="Read more" >...</a>

Original title:&nbsp;Comparison of Results of Transcatheter Aortic Valve Implantation in Patients with Severely Stenotic Bicuspid versus Tricuspid or Non-Bicuspid Valves.&nbsp;Reference:&nbsp;Charis Costopoulos et al. Am J Cardiol. 2014 Jan 31. pii: S0002-9149(14)00554-2. &nbsp; The bicuspid aortic valve (BAV) is the most common congenital cardiac malformation. It occurs in approximately 1% of the general population and often<a href="https://solaci.org/en/2014/03/11/transcatheter-valve-replacement-for-bicuspid-aortic-valve-stenosis/" title="Read more" >...</a>

Original title:&nbsp;Reduction of pacemaker implantation rates alter CoreValve implantation by moderate predilatation&nbsp;Reference:&nbsp;Philipp Lange, et al. EuroIntervention 2014;9:1151-1159 Aortic valve implantation has been proven a valid strategy to treat high risk patients. The CoreValve self-expanding transcatheter aortic valve is associated with a relatively high rate of permanent pacemaker implantation and, until now, no efforts have been<a href="https://solaci.org/en/2014/03/05/predilation-with-smaller-valvuloplasty-balloon-diameter-could-reduce-the-need-for-permanent-pacemaker-after-corevalve/" title="Read more" >...</a>

Original title:&nbsp;Cognitive trajectory after transcatheter aortic valve implantation.&nbsp;Reference:&nbsp;Ghanem A et al. Circulation Cardiovasc Intervent. 2013;Epub ahead of print &nbsp; Several studies showed that silent cerebral embolism in patients undergoing percutaneous aortic valve replacement is frequent but seems that does not affect the long-term cognitive functions according to this new study.&nbsp; This study included 111 patients<a href="https://solaci.org/en/2013/10/29/silent-cerebral-embolism-during-percutaneous-valve-implantation-does-not-appear-to-cause-cognitive-impairment/" title="Read more" >...</a>

Original title:&nbsp;Automated 3-Dimensional Aortic Annular Assessment by Multidetector Computed&nbsp;Tomography in Transcatheter Aortic Valve Implantation.&nbsp;Reference:&nbsp;Yusuke Watanabe et al.&nbsp;J Am Coll Cardiol Intv 2013;6:955&ndash;64. Percutaneous aortic valve implantation ( TAVI ) has emerged as an alternative for patients with severe aortic stenosis and high surgical risk. While this technique was improved over the time, residual paravalvular regurgitation<a href="https://solaci.org/en/2013/09/26/automatic-measurement-of-the-aortic-annulus-by-tac-more-precisely-to-choose-the-correct-valve-size/" title="Read more" >...</a>

Original title: Determinats and Outcomes of Acute transcatheter Valve-in Valve Therapy or Embolization.&nbsp;Reference:&nbsp;Raj R Makkar, et al. J Am Coll Cardiol 2013;62:418-30 &nbsp; Percutaneous aortic valve implantation has proven to be feasible, safe and a successful follow up. Only in a few patients is the two-valve implantation necessary due to bad positioning or embolism but<a href="https://solaci.org/en/2013/08/06/implanting-a-second-valve-and-embolization-are-two-complications-that-increase-mortality/" title="Read more" >...</a>

Original title:&nbsp;4-Year Results of a Randomized Controlled Trial of Percutaneous Repair Versus surgery for Mitral Regurgitation.&nbsp;Reference:&nbsp;Laura Mauri, et al. J Am Coll Cardiol 2013;62:317-28 Surgical treatment of mitral regurgitation (MR) is currently recommended by either valve replacement or valvuloplasty. Devices are being developed to address this disease giving the benefits of percutaneous treatments. The EVEREST<a href="https://solaci.org/en/2013/07/26/percutaneous-mitral-valve-treatment-is-a-valid-alternative-in-the-long-term/" title="Read more" >...</a>